14626 CDx EU homepage header

What is the Clinical Biomarkers & World CDx Europe Meeting?

Clinical Biomarkers & World CDx Europe is uniting biomarker, diagnostic and precision medicine leaders to advance clinically predictive biomarkers to proven IVDs. Improving patient outcomes and standard of care, this meeting is built for biomarker, translational, clinical, regulatory and commercial functions to tackle end-to-end challenges and deliver successful drug-Dx products.

How Will it Help You Deliver Predictive Markers & Effective Drug-Dx Products?

Built for biopharma, clinical and diagnostic teams, this meeting provides the opportunity to tackle your biggest roadblocks and uncover new opportunities in biomarker research and drug development.

You can hear from the likes of Merck KGaA, AstraZeneca, Regeneron & many many more for 2 days of in-depth case studies, interactive panel discussions, dedicated Q&A time and highly appraised online networking opportunities to meet and learn from industry trailblazers and precision medicine pioneers.

What’s more, our streamed format gives you the opportunity to tailor attendance to suit your needs, allowing you to get the best possible return from your attendance. Check out the full event guide to see what will be discussed!

Why Should You Attend?

Overcoming roadblocks in the development and delivery of clinically predictive markers are vital to delivering on the promise of precision medicine, increasing market share and breaking through competition.

If you are dedicated to streamlining the demonstration of therapeutic efficacy, maximizing clinical success or improving the market penetration of precision medicines, this is your place to be! Join the community that’s been with us now for over a decade.

What’s more, it's free to attend for drug developers and researchers! What’s not to love?

Jörg Engelbergs

Scientific-Regulatory Expert, Biomedicines & CDx

Paul-Ehrlich-Institut, Federal Institute for Vaccines & Biomedicines

Claudia Dollins

Head, Executive Director, Global Regulatory Affairs, Translational Medicine & Devices

Merck KGaA

Will Green

Project Director

York Health Economics Consortium

Rob Hastings

Precision Medicine Portfolio Lead, Cardiovascular, Renal & Metabolism

AstraZeneca

Hear What Our Attendees Say

"This is the best platform for digital conference I have attended this year, you have set the bar in my mind." - Debbie Robinson, Senior Director & Head of Program Management

Maverick Therapeutics

“Fantastic organisation along with facilitation of effective networking. Conference content well thought through covering major discussion points within the field of Companion Diagnostics & Clinical Biomarkers. Thank you.”

MiNA Therapeutics

“It was great as ever, both from content as well as networking opportunity. The Hanson Wade Team has again done a great job.”

TÜV SÜD

“The Hansonwade team are really on the ball when it comes to customer service, industry insights and understanding what makes an event work.  Great location this year and look forward to the next event!”

Definiens

Other Events in the Series